Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 154,386 |
|
|||||
| News | - | ||||||
| Day High | 18.70 | Low High |
|||||
| Day Low | 17.65 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| iTeos Therapeutics Inc | ITOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.245 | 1.36% | 18.295 | 14:13:04 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 18.04 | 17.65 | 18.70 | 18.05 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,224 | 154,386 | $ 18.18 | $ 2,806,193 | - | 8.20 - 18.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:13:04 | 100 | $ 18.295 | USD |
iTeos Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 655.93M | 35.84M | - | 12.6M | -112.64M | -3.14 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
iTeos Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ITOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.38 | 18.70 | 16.50 | 17.31 | 746,151 | 0.915 | 5.26% |
| 1 Month | 10.65 | 18.75 | 10.26 | 15.83 | 609,484 | 7.65 | 71.78% |
| 3 Months | 10.58 | 18.75 | 10.01 | 13.90 | 396,224 | 7.72 | 72.92% |
| 6 Months | 10.15 | 18.75 | 8.95 | 12.31 | 349,751 | 8.15 | 80.25% |
| 1 Year | 15.37 | 18.75 | 8.20 | 12.20 | 394,596 | 2.93 | 19.03% |
| 3 Years | 22.16 | 52.43 | 8.20 | 21.23 | 374,966 | -3.87 | -17.44% |
| 5 Years | 19.70 | 52.43 | 8.20 | 22.41 | 339,383 | -1.41 | -7.13% |
iTeos Therapeutics Description
| ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. |
